<DOC>
	<DOCNO>NCT00778765</DOCNO>
	<brief_summary>To compare single-dose oral bioavailability metformin HCI liquid 500 mg/5 mL Ranbaxy GlucophageÂ® 1000 mg tablet Bristol-Myers , USA follow administration 1000 mg dose healthy , adult , male female volunteer fast condition</brief_summary>
	<brief_title>Bioequivalence Study Gabapentin 400 mg Capsules Under Fed Conditions</brief_title>
	<detailed_description>This open-label , randomize , single-dose , 2-way crossover , relative bioavailability study perform 24 healthy adult volunteer 2 alternate . All 26 subject complete clinical phase study . In period , subject house even dose 36-hour blood draw . Single oral 400 mg dos separate washout period 7 day A total 24 healthy adult volunteer 2 alternate ( 17 male 9 non-pregnant female ) enrol complete clinical phase study</detailed_description>
	<mesh_term>Gabapentin</mesh_term>
	<mesh_term>gamma-Aminobutyric Acid</mesh_term>
	<criteria>1 . Healthy adult male female volunteer , 1855 year age 2 . Weighing least 52 kg male 45 kg female within 15 % ideal weight ( Table `` Desirable Weights Adults '' , Metropolitan Life Insurance Company , 1983 ) 3 . Medically healthy subject clinically normal laboratory profile 4 . Females childbearing potential either sexually inactive ( abstinent ) 14 day prior study throughout study use one follow acceptable birth control method : surgically sterile ( bilateral tubal ligation , hysterectomy bilateral oophorectomy ) 6 month minimum IUD place least 3 month barrier method ( condom , diaphragm ) spermicide least 14 day prior start study throughout study surgical sterilization partner ( vasectomy 6 month minimum ) hormonal contraceptive least 3 month prior start study Other birth control method may deem acceptable . Postmenopausal woman amenorrhea least 2 year eligible . 5 . Voluntarily consent participate study . Subject candidate must enrol study meet follow criterion : 1 . History presence significant cardiovascular , pulmonary , hepatic , renal , hematologic , gastrointestinal , endocrine , immunologic , dermatologic , neurologic , psychiatric disease 2 . In addition , history presence : alcoholism drug abuse within past 2 year hypersensitivity idiosyncratic reaction anticonvulsant 3 . Female subject pregnant lactate 4 . Subjects abnormal diet ( whatever reason ) 30 day prior first dose 5 . Subjects , completion study , would donate excess : 500 mL blood 14 day , 500 750 mL blood 14 day ( unless approve Principal Investigator ) 1000 mL blood 90 day 1250 mL blood 12 day 1500 mL blood 180 day 2000 mL blood 270 day 2500 mL blood I year 6 . Subjects participate another clinical trial within 28 day prior first dose</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>Bioequivalence gabapentin feed condition</keyword>
</DOC>